Literature DB >> 30126572

Antimicrobial Stewardship and Antimicrobial Resistance.

Louis B Rice1.   

Abstract

Antimicrobial stewardship programs aim to reduce costs, optimize therapeutic outcomes, and reduce antimicrobial resistance. Reductions of antimicrobial resistance are the most elusive because emergence and spread of resistant bacteria involves antimicrobial selective pressure and lapses in infection control techniques. The relationship between antimicrobial usage and resistance is not always direct. The understanding of which techniques are most effective is limited because many studies are descriptive or quasiexperimental. Recent meta-analyses or systematic reviews of stewardship programs offer encouragement that some interventions reduce overall antimicrobial selective pressure and, where associated with infection control interventions, impact resistance rates in individual institutions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimicrobial cycling; Antimicrobial resistance; Antimicrobial restriction; Antimicrobial stewardship; Decision support; Interventions

Mesh:

Substances:

Year:  2018        PMID: 30126572     DOI: 10.1016/j.mcna.2018.04.004

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  11 in total

1.  [Results of the Program for the Rational Use of Antimicrobials in a Mexican hospital, 2013-2018Resultados de um programa para o uso racional de antimicrobianos num hospital no México, 2013-2018].

Authors:  Oscar Sosa-Hernández; Claudia Vázquez-Zamora; Víctor Hugo Gutiérrez-Muñoz; Gustavo Esteban Lugo-Zamudio; Mónica Alethia Cureño-Díaz
Journal:  Rev Panam Salud Publica       Date:  2020-09-23

Review 2.  Inorganic Nanoparticles and Composite Films for Antimicrobial Therapies.

Authors:  Vera Alexandra Spirescu; Cristina Chircov; Alexandru Mihai Grumezescu; Bogdan Ștefan Vasile; Ecaterina Andronescu
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 3.  Antimicrobial Stewardship: A Review for Internal Medicine Physicians.

Authors:  Syeda Sahra; Abdullah Jahangir; Vincent De Chavez
Journal:  Cureus       Date:  2021-04-09

4.  Comparative Study of the Antimicrobial Effect of Nanocomposites and Composite Based on Poly(butylene adipate-co-terephthalate) Using Cu and Cu/Cu2O Nanoparticles and CuSO4.

Authors:  A F Jaramillo; S A Riquelme; G Sánchez-Sanhueza; C Medina; F Solís-Pomar; D Rojas; C Montalba; M F Melendrez; E Pérez-Tijerina
Journal:  Nanoscale Res Lett       Date:  2019-05-09       Impact factor: 4.703

5.  Editorial: Beyond Antimicrobials: Non-traditional Approaches to Combating Multidrug-Resistant Bacteria.

Authors:  Natalia V Kirienko; Laurence Rahme; You-Hee Cho
Journal:  Front Cell Infect Microbiol       Date:  2019-10-11       Impact factor: 5.293

Review 6.  Enterococci, from Harmless Bacteria to a Pathogen.

Authors:  Sónia Ramos; Vanessa Silva; Maria de Lurdes Enes Dapkevicius; Gilberto Igrejas; Patrícia Poeta
Journal:  Microorganisms       Date:  2020-07-25

7.  Antimicrobial Prescribing during Infant Hospital Admissions in a Birth Cohort in Dhaka, Bangladesh.

Authors:  Katherine Boone; Shaun K Morris; Sejal Doshi; Jason Black; Minhazul Mohsin; Tahmeed Ahmed; Abdullah Al Mahmud; Daniel E Roth
Journal:  J Trop Pediatr       Date:  2021-07-02       Impact factor: 1.165

8.  "Antibiotic hardstop" on electronic prescribing: impact on antimicrobial stewardship initiatives in patients with community acquired pneumonia (CAP) and infective exacerbations of chronic obstructive pulmonary disease (IECOPD).

Authors:  Semun Galimam; Brydon Panozzo; Kieran Muir; Ruchir Chavada
Journal:  BMC Infect Dis       Date:  2022-02-08       Impact factor: 3.090

Review 9.  Bacterial Resistance to Antimicrobial Agents.

Authors:  Manuel F Varela; Jerusha Stephen; Manjusha Lekshmi; Manisha Ojha; Nicholas Wenzel; Leslie M Sanford; Alberto J Hernandez; Ammini Parvathi; Sanath H Kumar
Journal:  Antibiotics (Basel)       Date:  2021-05-17

10.  Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial.

Authors:  Thomas Lodise; Joe Yang; Laura A Puzniak; Ryan Dillon; Marin Kollef
Journal:  Infect Dis Ther       Date:  2020-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.